Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins
Marc Emmenegger, Sreedhar Saseendran Kumar, Vishalini Emmenegger, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 12, pp. e1010118-e1010118
Open Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

The immunology of long COVID
Daniel M. Altmann, Emily M. Whettlock, Siyi Liu, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 618-634
Open Access | Times Cited: 265
Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies
Jan Damoiseaux, Arad Dotan, Marvin J. Fritzler, et al.
Autoimmunity Reviews (2021) Vol. 21, Iss. 3, pp. 103012-103012
Open Access | Times Cited: 79
Autoantibodies in COVID‐19 correlate with antiviral humoral responses and distinct immune signatures
Patrick Taeschler, Carlo Cervia, Yves Zurbuchen, et al.
Allergy (2022) Vol. 77, Iss. 8, pp. 2415-2430
Open Access | Times Cited: 51
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
August Jernbom Falk, Lovisa Skoglund, Elisa Pin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
The relationship between chronic immune response and neurodegenerative damage in long COVID-19
José Pedro Elizalde-Díaz, Clara Leticia Miranda-Narváez, Juan Carlos Martínez‐Lazcano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
From Co-Infections to Autoimmune Disease via Hyperactivated Innate Immunity: COVID-19 Autoimmune Coagulopathies, Autoimmune Myocarditis and Multisystem Inflammatory Syndrome in Children
Robert Root‐Bernstein
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 3001-3001
Open Access | Times Cited: 22
Aged brain and neuroimmune responses to COVID-19: post-acute sequelae and modulatory effects of behavioral and nutritional interventions
Ludmila Müller, Svetlana Di Benedetto
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 22
COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors
Daniele Focosi, Massimo Franchini, Liise‐anne Pirofski, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1594-1594
Open Access | Times Cited: 40
COVID-19 and antiphospholipid antibodies
Ayesha Butt, Doruk Erkan, Alfred Ian Lee
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101402-101402
Open Access | Times Cited: 24
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large metropolitan region
Marc Emmenegger, Elena De Cecco, David Lamparter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 37
Lack of association between pandemic chilblains and SARS-CoV-2 infection
Jeff Gehlhausen, Alicia J. Little, Christine J. Ko, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 22
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
Marc Emmenegger, Sebastian Fiedler, Silvio D. Brugger, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104766-104766
Open Access | Times Cited: 20
Molecular/antigenic mimicry and immunological cross-reactivity explains SARS-CoV-2-induced autoimmunity
Yekbun Adıgüzel, Dimitrios P. Bogdanos, Yehuda Shoenfeld
Autoimmunity Reviews (2025), pp. 103811-103811
Closed Access
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma
Matthias M. Schneider, Marc Emmenegger, Catherine K. Xu, et al.
Life Science Alliance (2021) Vol. 5, Iss. 2, pp. e202101270-e202101270
Open Access | Times Cited: 26
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
Marc Emmenegger, Elena De Cecco, David Lamparter, et al.
iScience (2023) Vol. 26, Iss. 2, pp. 105928-105928
Open Access | Times Cited: 10
TLR7 and IgM: Dangerous Partners in Autoimmunity
Timm Amendt, Philipp Yu
Antibodies (2023) Vol. 12, Iss. 1, pp. 4-4
Open Access | Times Cited: 8
The ASC inflammasome adapter governs SAA-derived protein aggregation in inflammatory amyloidosis
Marco Losa, Marc Emmenegger, Pierre De Rossi, et al.
EMBO Molecular Medicine (2024) Vol. 16, Iss. 9, pp. 2024-2042
Open Access | Times Cited: 3
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection
Brian Walitt, Tory P. Johnson
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 384-391
Closed Access | Times Cited: 12
Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19
August Jernbom Falk, Lovisa Skoglund, Elisa Pin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2
Viola Denninger, Catherine K. Xu, Georg Meisl, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 4, pp. 790-799
Open Access | Times Cited: 9
Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling
Marc Emmenegger, Roland Worth, Sebastian Fiedler, et al.
STAR Protocols (2023) Vol. 4, Iss. 1, pp. 102095-102095
Open Access | Times Cited: 5
Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk
Marc Emmenegger, Vishalini Emmenegger, Srikanth Mairpady Shambat, et al.
Clinical Immunology (2023) Vol. 257, pp. 109845-109845
Open Access | Times Cited: 4
The Cystic Fibrosis Transmembrane Regulator Controls Tolerogenic Responses to Food Allergens in Mice and Humans
Marc Emmenegger, Chrysoula Zografou, Yile Dai, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
The role of the intestinal microbiome in antiphospholipid syndrome
Dagmar J. M. van Mourik, Dorien M. Salet, Saskia Middeldorp, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Autoantibodies in COVID-19 correlate with anti-viral humoral responses and distinct immune signatures
Patrick Taeschler, Carlo Cervia, Yves Zurbuchen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top